Christopher K. Cox (META) discloses multiple sales totaling 15,000 Class A shares

Rhea-AI Filing Summary

Christopher K. Cox, Chief Product Officer at Meta Platforms (META), reported multiple sales of Class A common stock executed on 08/06/2025 under a Rule 10b5-1 trading plan adopted May 5, 2025. The filing lists seven sale tranches of 2,266, 983, 2,451, 1,421, 5,921, 1,560 and 398 shares, which together total 15,000 shares, sold at weighted-average prices with ranges approximately from $764.235 to $770.88 per share. After these transactions the Form 4 shows 222,205 Class A shares held of record by the Christopher K. Cox Revocable Trust and 55,046 shares held by the Cox-Vadakan Irrevocable Remainder Trust. The sales were disclosed on Form 4 and signed by an attorney-in-fact.

Positive

• Sales executed under a Rule 10b5-1 trading plan adopted May 5, 2025, indicating prearranged dispositions.
• Detailed price disclosure: filing includes weighted-average prices and explicit price ranges for each tranche, improving transparency.
• Substantial post-sale holdings disclosed: 222,205 shares in the Christopher K. Cox Revocable Trust and 55,046 shares in the Cox-Vadakan Irrevocable Remainder Trust.

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider sales of 15,000 META shares executed under a documented 10b5-1 plan; disclosure is granular and appears routine.

The filing reports seven tranches sold on 08/06/2025 under a Rule 10b5-1 plan adopted May 5, 2025, with weighted-average prices and explicit price ranges provided in footnotes. The detailed tranche sizes and price bands reduce ambiguity about execution pricing. The reporting person retains material indirect holdings in two trusts as disclosed, which limits interpretation that the sales exhausted insider ownership. Overall this reads as prearranged, routine disposition rather than a surprise market event.

Corporate Governance Expert

TL;DR: Use of a 10b5-1 plan and explicit price-range footnotes improves governance transparency; disclosure follows Form 4 standards.

The report specifies that the sales were effected pursuant to a 10b5-1 trading plan adopted May 5, 2025, and provides weighted-average prices plus price ranges for each tranche. The filing also lists indirect beneficial ownership via the Christopher K. Cox Revocable Trust and the Cox-Vadakan Irrevocable Remainder Trust. From a governance perspective, prearranged plan execution and granular price disclosure reduce potential signaling risk and increase transparency for shareholders and regulators.

Insider Trade Summary

Net Seller: 15,000 shares ($11,517,049)

Net Sell 8 txns

Insider Cox Christopher K

Role Chief Product Officer

Sold 15,000 shs ($11.52M)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	2,266	$764.739	$1.73M
Sale	Class A Common Stock	983	$765.4284	$752K
Sale	Class A Common Stock	2,451	$766.7718	$1.88M
Sale	Class A Common Stock	1,421	$768.0725	$1.09M
Sale	Class A Common Stock	5,921	$768.9923	$4.55M
Sale	Class A Common Stock	1,560	$769.8574	$1.20M
Sale	Class A Common Stock	398	$770.7644	$307K
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 234,939 shares (Indirect, Christopher K. Cox Revocable Trust)

Footnotes (1)

1. The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2025. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $764.235 to $765.195 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $765.25 to $766.055 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $766.31 to $767.13 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $767.50 to $768.49 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $768.50 to $769.44 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $769.505 to $770.14 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $770.58 to $770.88 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cox Christopher K

(Last) (First) (Middle)

C/O META PLATFORMS, INC.

1 META WAY

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Meta Platforms, Inc. [ META ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/06/2025		S(1)		2,266	D	$764.739(2)	234,939	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/06/2025		S(1)		983	D	$765.4284(4)	233,956	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/06/2025		S(1)		2,451	D	$766.7718(5)	231,505	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/06/2025		S(1)		1,421	D	$768.0725(6)	230,084	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/06/2025		S(1)		5,921	D	$768.9923(7)	224,163	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/06/2025		S(1)		1,560	D	$769.8574(8)	222,603	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock	08/06/2025		S(1)		398	D	$770.7644(9)	222,205	I	Christopher K. Cox Revocable Trust(3)
Class A Common Stock								55,046	I	Cox-Vadakan Irrevocable Remainder Trust(10)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2025.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $764.235 to $765.195 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $765.25 to $766.055 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $766.31 to $767.13 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $767.50 to $768.49 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $768.50 to $769.44 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $769.505 to $770.14 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $770.58 to $770.88 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

10. Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.

	/s/ Erin Guldiken, attorney-in-fact for Christopher K. Cox	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for META?

The Form 4 was filed on behalf of Christopher K. Cox, Chief Product Officer of Meta Platforms (META); the signature on the filing was provided by an attorney-in-fact.

What transactions are reported in the META Form 4?

The filing reports multiple sales of Class A common stock executed on 08/06/2025 under a Rule 10b5-1 trading plan.

How many shares did Christopher K. Cox sell and what were the prices?

Seven tranches of 2,266; 983; 2,451; 1,421; 5,921; 1,560; and 398 shares were sold (totaling 15,000 shares) at weighted-average prices with ranges approximately $764.235 to $770.88 per share.

When was the 10b5-1 trading plan adopted for these META sales?

The Form 4 states the Rule 10b5-1 trading plan was adopted on May 5, 2025.

How many META shares does Cox beneficially hold after the transactions?

The filing shows 222,205 Class A shares held of record by the Christopher K. Cox Revocable Trust and 55,046 shares held by the Cox-Vadakan Irrevocable Remainder Trust.